Trial intelligence / Profile preview

Ghrelin in Cancer Patients With Progressive Weight Loss

NCT00681486Phase 3Completed

Sponsor
University of Gothenburg
Start
Oct 2003
Primary completion
Jun 2008
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of human ghrelin in cancer cachexia (2 arms), sponsored by University of Gothenburg. Primary endpoint: Food intake. Started Oct 2003; status: completed.

02

Drugs

human ghrelin
03

Conditions

cancer cachexia

Beyond the preview

Go deeper on NCT00681486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00681486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call